ADPT Competitors & Alternatives
Compare Adaptive Biotechnologies Corp with similar stocks in the same industry
Diagnostics & Research
ADPT
Main Stock$17.69
Tradestie Score
59
Market Cap
$2.22B
Revenue Growth
0.4%
Analyst Upside
+13.9%
Top Competitors
36 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SHC
Sotera Health Company Common Stock
|
$15.86
|
$4.60B | 38.6 | 56 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$59.50
|
$3.26B | - | 62 | Compare |
|
VCYT
Veracyte, Inc.
|
$53.45
|
$2.85B | 49.7 | 62 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$36.22
|
$2.44B | - | 69 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$62.54
|
$2.24B | - | 59 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$86.29
|
$1.77B | - | 59 | Compare |
|
TXG
10x Genomics, Inc. Class A Common Stock
|
$32.92
|
$1.54B | - | 55 | Compare |
|
NEOG
Neogen Corp
|
$9.00
|
$1.26B | - | 61 | Compare |
|
OPK
Opko Health Inc.
|
$1.49
|
$1.23B | - | 60 | Compare |
|
NEO
NeoGenomics, Inc.
|
$11.27
|
$1.13B | - | 55 | Compare |
More ADPT Analysis
Data updated: Jun 23, 2026 | Industry: Diagnostics & Research (SIC 2836)
36 stocks in this industry